| Literature DB >> 16472654 |
Gerd Haug1, Holger Barth, Klaus Aktories.
Abstract
C3 exoenzyme from Clostridium limosum, specifically ADP-ribosylates and inactivates Rho GTPases, but not or much less than Rac and Cdc42. To bypass the poor cell accessibility of the exoenzyme, a chimeric fusion toxin was constructed consisting of C3 exoenzyme and the N-terminal adaptor domain of the enzyme component C2I of the actin-ADP-ribosylating Clostridium botulinum C2 toxin. This fusion toxin C2IN-C3 is transported into cells by interaction with the binding and translocation component (C2II) of C2 toxin. Purification and activity of the chimeric toxin is reported.Entities:
Mesh:
Substances:
Year: 2006 PMID: 16472654 DOI: 10.1016/S0076-6879(06)06010-1
Source DB: PubMed Journal: Methods Enzymol ISSN: 0076-6879 Impact factor: 1.600